Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Shaw

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 1, 1997
Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controlsG L Shaw, B Weiffenbach, R T Falk, et al.
Human Molecular Genetics|June 1, 1994
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeR Saxena, G L Shaw, M V Relling, et al.
Journal of the National Cancer Institute|October 3, 1990
Effect of diurnal variation on debrisoquine metabolic phenotypingG L Shaw, R T Falk, N E Caporaso, et al.
Structure (London, England : 1993)|July 15, 1994
The solution structure and dynamics of the DNA-binding domain of HMG-D from Drosophila melanogasterD N Jones, M A Searles, G L Shaw, et al.
Biological Cybernetics|March 17, 2001
Reliable short-term memory in the trion model: toward a cortical language and grammarM Sardesai, C Figge, M Bodner, et al.
Cancer Causes & Control : CCC|May 1, 1993
Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States)J F Dorgan, R G Ziegler, J B Schoenberg, et al.
Environmental Health Perspectives|November 1, 1992
The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotypeN E Caporaso, P G Shields, M T Landi, et al.
Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Debrisoquine metabolism and lung cancer riskG L Shaw, R T Falk, J Deslauriers, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Lung Cancer (Amsterdam, Netherlands)|May 1, 1997
Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controlsG L Shaw, B Weiffenbach, R T Falk, et al.
Human Molecular Genetics|June 1, 1994
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeR Saxena, G L Shaw, M V Relling, et al.
Journal of the National Cancer Institute|October 3, 1990
Effect of diurnal variation on debrisoquine metabolic phenotypingG L Shaw, R T Falk, N E Caporaso, et al.
Structure (London, England : 1993)|July 15, 1994
The solution structure and dynamics of the DNA-binding domain of HMG-D from Drosophila melanogasterD N Jones, M A Searles, G L Shaw, et al.
Biological Cybernetics|March 17, 2001
Reliable short-term memory in the trion model: toward a cortical language and grammarM Sardesai, C Figge, M Bodner, et al.
Cancer Causes & Control : CCC|May 1, 1993
Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States)J F Dorgan, R G Ziegler, J B Schoenberg, et al.
Environmental Health Perspectives|November 1, 1992
The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotypeN E Caporaso, P G Shields, M T Landi, et al.
Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1995
Debrisoquine metabolism and lung cancer riskG L Shaw, R T Falk, J Deslauriers, et al.
Pageof 7